TNFSF10 and neoplasm: Tumor necrosis factor-related apoptosis inducing ligand (TRAIL), a member of the TNF family, is a potential cancer agent due to its tumor-specific induction of apoptosis and human recombinant TRAIL is being tested in clinical trials for various cancer types (8–12).